Zhejiang Huahai Pharmaceutical Co., Ltd. (600521.SS) SHH

Currency In CNY

AD

Valuation

Market Cap25.17B
Enterprise Value32.33B
P/E Ratio36.55
PEG Ratio-1.64
Price/Sales Ratio2.56
Price/Book Ratio2.34
Enterprise/Revenue3.34
Enterprise/EBITDA24.57

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.08
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.07

Income Statement

Revenue8.54B
Revenue/Share6.03
Gross Profit4.7B
EBITDA1.59B
Net Income266.94M
Diluted EPS0.18

Balance Sheet

Total Cash1.96B
Total Cash/Share1.32
Total Debt8.85B
Total Debt/Equity0.9
Current Ratio1.05
Book Value Per Share7.18

Price History

52-Week Change-34.79
52-Week High25.57
52-Week Low13.73
Moving Average 50 Days16.66
Moving Average 200 Days16.3

Statistics

Average Volume36.79M
Shares Outstanding1.5B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.1
Trailing Annual Dividend Yield0.65
Payout Ratio0.46
Last Split Factor11:10
Last Split DateJune 08, 2020
AD